Work

Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax

Year: 2022

Type: article

Study design: Observational Study

Source: Leukemia Research

DOI: 10.1016/j.leukres.2022.106942

Authors: Jan Philipp Bewersdorf, Rory M. Shallis, Andriy Derkach, Aaron D. Goldberg, Anthony Stein, Eytan M. Stein, Guido Marcucci, Amer M. Zeidan, Shai Shimony, Daniel J. DeAngelo, Richard M. Stone, Ibrahim Aldoss, Brian J. Ball, Maximilian Stahl

Institutions: Memorial Sloan Kettering Cancer Center, Yale Cancer Center, Yale University, City Of Hope National Medical Center, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Award: G5487787631

OpenAlex ID: W4293473168

FWCI: 3.736

Cites: 17

Cited by: 28

Related to: 10